MILFORD, Mass., May 28, 2025 /PRNewswire/ -- Waters Corporation (NYSE:WAT) today announced the launch of the BioResolve™ Protein A Affinity Columns with MaxPeak™ Premier Technology, providing precise ...
Downstream bioprocessing steps have long been a challenge to drug manufacturers, particularly the chromatography step for purification of monoclonal antibodies (mAbs). The complexity of traditional ...
MILFORD, Mass.--(BUSINESS WIRE)--Waters Corporation (WAT:NYSE) today introduced new size exclusion chromatography (SEC) columns for the characterization of proteins. For use with Waters ® Alliance ® ...
In recent years, monoclonal antibodies (mAbs) have become one of the major biopharma products in response to the need to treat various diseases. These antibodies have been engineered with a specific ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback